Abstract
The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hodgens A, Gupta V. Severe Acute Respiratory Syndrome. In: StatPearls [Internet]. StatPearls Publishing; 2021. Accessed May 10, 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558977/
Smith R. Did we eradicate SARS? Lessons learned and the way forward. American Journal of Biomedical Science and Reserch. 2019;6:AJBSR.MS.ID.001017.
World Health Organization. WHO Coronavirus (Covid-19) Dashboard. Accessed May 11, 2021. Available from: https://covid19.who.int/
World Health Organization. Covax. Accessed May 11, 2021. Available from: https://www.who.int/initiatives/act-accelerator/covax
The Independent Panel for Pandemic Preparedness & Response. Main Report. COVID-19: Make it the last pandemic. 2021;42–43. Accessed 20 May, 2021. Available from: theindependentpanel.org/documents-linked-to-co-chairs-presentation-of-findings-and-recommendations/
John TJ. Will coronavirus pandemic eventually evolve as pan-endemic? Current Science. 2020;118:855–56.
Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ 1998;76:23–5.
Lee BY, Bartsch SM, Ferguson MC, et al. The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. PLoS Comput Biol. 2021;17:e1008470.
Lesham E, Lopman BA. Population immunity and vaccine protection against infection. Lancet. 2021;397:1686–87.
John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol. 2000;16:601–6.
Leshem E, Wilder-Smith A. COVID-19 vaccine impact in Israel and a way out of the pandemic. Lancet. 2021:S0140-6736(21)01018-7.
Vavrek D, Speroni L, Curnow KJ, et al. Genomic surveillance at scale is required to detect newly emerging strains at an early time point [pre-print]. medRxiv 2021.01.12.21249613.
John TJ, Dharmapalan D. The time to begin plans for COVID-19 eradication is now. Christ Journal of Global Health. 2020;7.
Johansen MD, Irving A, Montagutelli X, et al. Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunol. 2020;13:877–91.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding
None
Competing interests
None stated.
Rights and permissions
About this article
Cite this article
Dharmapalan, D., John, T.J. COVID-19 Eradication for Vaccine Equity in Low Income Countries. Indian Pediatr 58, 970–972 (2021). https://doi.org/10.1007/s13312-021-2333-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-021-2333-0